type-II aurora-B kinase inhibitors (National Taiwan University)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug Nametype-II aurora-B kinase inhibitors (National Taiwan University)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerine/threonine-protein kinase Aurora-B inhibitors
TargetsSerine/threonine-protein kinase Aurora-B
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryTaiwan
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesNational Taiwan University
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNational Taiwan University
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A